OriGene Technologies, Inc.
Search:    
About FL cDNA Clones RNAi Gene Expression Lysates and Proteins Antibodies Tissue Other Products Tech Support
orange


OriGene TissueScan in recent publications
Circulating Adiponectin Is Inversely Associated with Risk of Thyroid Cancer: In Vivo and in Vitro Studies J. Clin. Endocrinol. Metab., Dec 2011; 96: E2023 - E2028. [four normal thyroid tissue specimens ]

QKI-Mediated Alternative Splicing of the Histone Variant MacroH2A1 Regulates Cancer Cell Proliferation Mol. Cell. Biol., Oct 2011; 31: 4244 - 4255. [Breast Tissue RNA]

Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. J Mol Diagn. 2011 Sep;13(5):493-503. [Tumor Tissue]

Inhibition of miR-193a Expression by Max and RXRa Activates K-Ras and PLAU to Mediate Distinct Aspects of Cellular Transformation Cancer Res., Aug 2011; 71: 5144 - 5153. [RNAs from colon adenocarcinomas  ]

spacer

Advanced Tools for Cancer Biomarker Discovery and Validation

divider

As a gene-centric company, OriGene has developed unique technologies and products for cancer biomarker discovery and validation

  1. Most comprehensive human cancer tissue biorepository
    • >140,000 tissue collections
    • Collected under strict IRB and ethical consenting practices
    • Annotated with associated clinical data
  2. TissueScan Cancer qPCR Arrays – mRNA expression profiling
    • Panels of normalized cDNA prepared from tumor tissues, ready for qPCR
    • Broad tumor coverage – Multiple panels for breast, colon, lung, ovarian, and prostate cancers
    • Convenient and fast – qPCR ready format; results in less than 2 hours.
  3. ProteoScan Cancer Lysate Arrays – protein expression profiling
    • High-density reverse-phase protein arrays (RPPA) spotted with cancer and normal tissue lysates
    • 432 tissue lysates from pathologist-verified normal and cancer specimens
    • 11 cancers represented (25 cancer samples +15 normal samples per cancer type)
  4. Cancer-pathway specific qPCR primer Panels
    • 21 pre-designed key cancer pathways
    • qPCR screening-ready format
    • Custom panels available

 

divider
Inc 5000 Healthcare Company Copyright © 2012 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436


Reproduction of any materials from this website is strictly forbidden without permission.